Can a blood test spot hidden heart strain during breast cancer surgery?
NCT ID NCT01754597
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study measured levels of a heart stress marker called NT-proBNP in 54 breast cancer patients during surgery. All patients had previously received anthracycline chemotherapy, which can weaken the heart. Researchers wanted to see if anesthesia might add extra stress. The goal was to find a simple way to detect early heart problems during surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help identify a simple blood test to monitor heart function during surgery in patients who have had anthracycline chemotherapy.
- What could go wrong
- This is a small pilot study with only 54 participants, so results may not apply to all patients. It only measures a biomarker, not actual heart outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institut Bergonié
Bordeaux, Aquitaine, 33000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?